pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: | Completed |
---|---|
Conditions: | Liver Cancer, Cancer, Gastrointestinal |
Therapuetic Areas: | Gastroenterology, Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/7/2015 |
Start Date: | April 2012 |
End Date: | September 2013 |
Contact: | Adam Sliva, MD |
Email: | slivax@UPMC.EDU |
Phone: | (412) 647-8132 |
This study will collect data from patients undergoing an ERCP procedure with probe-based
Confocal Laser Endomicroscopy for suspicion of bile duct cancer. the objective is to
evaluate the diagnostic performance of pCLE for the diagnosis of indeterminate biliary
stricture when associated with other diagnostic information (standard ERCP and tissue
sampling).
Confocal Laser Endomicroscopy for suspicion of bile duct cancer. the objective is to
evaluate the diagnostic performance of pCLE for the diagnosis of indeterminate biliary
stricture when associated with other diagnostic information (standard ERCP and tissue
sampling).
This trial aims at evaluating the performance diagnosis of pCLE for the detection of bile
duct cancer, in patients with indeterminate biliary stricture when associated with other
diagnostic information.
The hypothesis is that ERCP with Cellvizio probe-based endomicroscopy improves
differentiation of biliary and pancreatic duct lesions versus ERCP alone or ERCP with tissue
sampling, by improving the sensitivity of detection and by providing a real-time diagnosis.
Direct measures of accuracy (sensitivity, specificity, etc.) in the differentiation of
malignant versus benign biliary duct lesions will be compared for the combination of ERCP
alone, endomicroscopy plus ERCP imaging, and ERCP plus endomicroscopy plus tissue sampling.
These information will be reviewed retrospectively by a second physician.
These presumptive diagnoses will be compared against a 12-month follow-up confirmed
histopathologic endpoint (an initially-benign pathologic diagnosis will be confirmed by a
12-month follow-up). Secondary objectives include collecting patient management
recommendation. Yet, effective management recommendation is left as the discretion of the
physician.
duct cancer, in patients with indeterminate biliary stricture when associated with other
diagnostic information.
The hypothesis is that ERCP with Cellvizio probe-based endomicroscopy improves
differentiation of biliary and pancreatic duct lesions versus ERCP alone or ERCP with tissue
sampling, by improving the sensitivity of detection and by providing a real-time diagnosis.
Direct measures of accuracy (sensitivity, specificity, etc.) in the differentiation of
malignant versus benign biliary duct lesions will be compared for the combination of ERCP
alone, endomicroscopy plus ERCP imaging, and ERCP plus endomicroscopy plus tissue sampling.
These information will be reviewed retrospectively by a second physician.
These presumptive diagnoses will be compared against a 12-month follow-up confirmed
histopathologic endpoint (an initially-benign pathologic diagnosis will be confirmed by a
12-month follow-up). Secondary objectives include collecting patient management
recommendation. Yet, effective management recommendation is left as the discretion of the
physician.
Inclusion Criteria:
- Male or female > 18 years of age
- Indicated for ERCP for indeterminate bile duct stricture
- Referral patients with indeterminate biliary stricture coming in for first ERCP
procedure at referral institution or
- Patients who had previous non-diagnostic tissue sampling (brushing biopsies or
EUS-FNA) taken during a previous ERCP or EUS-FNA for an indeterminate biliary
stricture
- Willing and able to comply with study procedures and provide written informed consent
to participate in the study
Exclusion Criteria:
- Subjects for whom ERCP procedures are contraindicated
- Known allergy to fluorescein dye
- Patients suffering Primary Sclerosing Cholangitis or chronic pancreatitis.
- Patients with post-transplant stricture
- If female, pregnant based on a positive hCG serum or an in vitro diagnostic test
result or breast-feeding
We found this trial at
4
sites
Click here to add this to my saved trials
Yale-New Haven Hospital Relying on the skill and expertise of more than 4,500 university and...
Click here to add this to my saved trials
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
Click here to add this to my saved trials
Virginia Mason Medical Center Established in 1920, Virginia Mason began as an 80-bed hospital with...
Click here to add this to my saved trials